iHeartMedia IHRT Stock Risk Reversal Explodes Higher 20260418 GLBE GlobalE Online Ltd Ordinary Shares Q4 2025 earnings beat estimates revenue grows 278 percent year over year shares edge higher AEye Inc LIDRW Stock Undervalued Signal Mini Selloff 20260418 Maase Inc MAAS Competitive Advantages Maase Inc posts huge revenue steep negative EPS Oracle Corporation ORCL Valuation Assessment Following 46 12Month Share Price Rally Market Wrap Tech leads sectors as consumer lags and markets see mild dips What is the outlook for Citi TruPS CN stock today CN Earnings Citi TruPS reports no EPS or revenue metrics vs market estimates Congressman Kean Maintains Stock Trading Activity Amid Extended Washington Absence ValueQuests Sameer Shah Advocates Private Equity Approach to Public Markets for LongTerm Alpha Analysts Identify Adani Power Netweb Technologies and Others for Potential NearTerm Gains Amid Market Weakness Corporate Confidence in Prediction Markets Grows Despite Regulatory Uncertainty Ashiana Housing to Develop Premium Residential Project in Jaipur with Rs 560 Crore Investment Boston Red Sox Organizational Move Risks Franchise Value After Varitek Decision Haemonetics Q1 2026 Earnings EPS Slightly Exceeds Estimates Stock Rises 57 DSX Q4 2025 Earnings EPS Misses Estimates by Wide Margin Stock Declines UZD Q1 2026 Earnings Significant EPS Beat Drives Stock Uptick ODD Q4 2025 Earnings Earnings Beat on Strong EPS Surprise SPRU Q1 2026 Earnings Negative EPS but Positive Market Momentum Amid Strategic Shift MSEX Q1 2026 Earnings Earnings Miss Estimates as Operating Pressures Mount Logitech International LOGI Surges 646 Bulls Test Key Resistance Zone Olenox Industries OLOX Edges Lower Holds Above Key Support Level Flushing Financial Stock Slips as Resistance Holds Firm Marine Petroleum Trust MARPS Holds Steady Near Key Support Level Wolverine World Wide WWW Edges Higher as Stock Tests Key Resistance Zone Stan Lees AI Voice Revival ElevenLabs Deal Brings Marvel Legend Back to Life PLPC Q1 2026 Earnings EPS Surges Past Estimates with 1528 Surprise Palvella Therapeutics PVLA Shows Resilience with Slight Gain Testing Key Resistance